Drug class
Third-generation oral cephalosporin beta-lactam antibacterial
Mechanism of action
Binds penicillin-binding proteins and inhibits the final transpeptidation step of bacterial peptidoglycan cell-wall synthesis, producing bactericidal activity against susceptible organisms.
General use cases
- Treatment of infections caused by cefixime-susceptible bacteria, including selected urinary-tract infections, otitis media, pharyngitis/tonsillitis and acute exacerbations of chronic bronchitis
- Treatment of uncomplicated gonorrhoea only where recommended by current local antimicrobial guidance and susceptibility patterns; exact approved indications vary by jurisdiction
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
